Ofatumumab Intravenous and Signifor (Pasireotide Extended-Release Injection)
Determining the interaction of Ofatumumab Intravenous and Signifor (Pasireotide Extended-Release Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ofatumumab
Brand name: Arzerra
Synonyms: Ofatumumab
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ofatumumab Intravenous-Signifor (Pasireotide Injection)
- Ofatumumab Intravenous-Signifor Injection
- Ofatumumab Intravenous-Signifor LAR
- Ofatumumab Intravenous-Signifor LAR Injection
- Ofatumumab Intravenous-Siklos
- Ofatumumab Intravenous-Siladryl Allergy
- Signifor (Pasireotide Extended-Release Injection)-Ofev
- Signifor (Pasireotide Extended-Release Injection)-Off-Ezy Topical
- Signifor (Pasireotide Extended-Release Injection)-Ofirmev
- Signifor (Pasireotide Extended-Release Injection)-Ofloxacin
- Signifor (Pasireotide Extended-Release Injection)-Ofloxacin (Systemic)
- Signifor (Pasireotide Extended-Release Injection)-Oforta